Related by context. All words. (Click for frequent words.) 79 acute peripheral arterial 76 R Saizen R 75 occlusion PAO 75 catheter occlusion CO 74 induced macular edema 74 CYT# potent vascular disrupting 74 vapreotide acetate 74 Initiates Enrollment 73 prokinetic agent 73 Phase #b/#a clinical 73 Pivotal Phase III 73 novel VDA molecule 73 Serostim ® 73 acetonide FA 73 including eniluracil ADH 73 Meets Primary Endpoint 73 myocardial infarction ventricular fibrillation 73 sodium thiosulfate STS 73 sapropterin dihydrochloride Tablets 73 hyperphenylalaninemia HPA due 73 Personalized Immunotherapy 73 methylnaltrexone bromide 72 brand ciclesonide HFA 72 Vascugel 72 SUPPRELIN R LA 72 kidney urologic 72 oral prodrug 72 lintuzumab SGN 72 Zorbtive TM 72 vitreoretinal disorders 72 retinal vein occlusion induced 72 R lenalidomide 72 SinuNase TM 72 lexidronam injection 72 octreotide implant 72 MKC# MT 72 undergoing elective percutaneous 72 metastatic malignant 72 treat dysmenorrhea 72 erlotinib Tarceva ® 72 Intravitreal 72 NAVISTAR R 71 fallopian tube cancers 71 delivers fluocinolone acetonide FA 71 Ophena TM 71 pain palliation 71 Achieves Primary Endpoint 71 essential thrombocythemia ET 71 Frozen Shoulder syndrome Adhesive 71 Ovitrelle R Serostim 71 non splenectomized 71 Perforomist ™ Inhalation Solution 71 opioid induced bowel dysfunction 71 FUSILEV ® 71 esophageal candidiasis 71 XL# anticancer compounds 71 docetaxel Taxotere ® 71 CTAP# Capsules 71 CIMZIA TM certolizumab pegol 71 sapropterin dihydrochloride 71 orally administered inhibitor 71 toenail onychomycosis 71 ALVESCO ® 71 FDA APPROVES 71 treat chronic sinusitis 71 modified glutathione analog 71 TO AVOID PREGNANCY WHILE 71 Pivotal Trial 71 Completes Patient Enrollment 71 Pivotal Clinical Trial 71 Genasense ® oblimersen 71 Loceryl ® 71 TM Drug Eluting 71 Intravitreal injections 71 metastatic colorectal 71 GEM OS2 71 MAGE A3 ASCI 71 R sorafenib tablets 71 oropharyngeal candidiasis OPC 71 PEGylated anti 71 ELADUR ™ 70 Vidaza ® 70 herpetic keratitis 70 dasatinib Sprycel ® 70 BCG refractory carcinoma 70 Phase 2b Clinical Trial 70 Dementia Related Psychosis 70 AERx ® 70 Clolar ® 70 topically applied SEPA 70 PEGINTRON TM 70 gastrointestinal mucositis 70 Phase IIb Trial 70 Entereg R 70 Besivance 70 Cerebril TM 70 endoluminal stent graft 70 lucinactant 70 colesevelam HCl 70 ® lenalidomide 70 Known hypersensitivity 70 deep venous thromboses 70 relapsed MM 70 ACTEMRA TM 70 targeted radiotherapeutic 70 haematologic 70 alvespimycin 70 cisplatin gemcitabine 70 myelodysplastic myeloproliferative diseases 70 Anti VEGF 70 vaginal candidiasis 70 CTAP# 70 refractory chronic lymphocytic 70 steroid refractory 70 oral nucleoside analogue 70 Completes Enrollment 70 OMNARIS HFA 70 FUSILEV enhances 70 2 methoxyestradiol 70 delivery polymer matrix 70 Gel repository corticotropin injection 70 Crofelemer budesonide foam 70 XP# XP# 70 hypoxia activated prodrug 70 LymphoStat B TM 70 Microplasmin 70 interferon beta 1a infertility 70 Patients Treated With 70 TNF Tumor Necrosis Factor 70 oncolytic virus therapies 70 candidates Azedra TM 69 systemic anaplastic large 69 Initiates Phase II 69 personalized cellular immunotherapy 69 IL# PE#QQR 69 dihydrochloride Tablets 69 Solazed TM 69 aneurysms AAA 69 evaluating tivozanib 69 oxymorphone ER 69 diarrhea predominant irritable 69 dextromethorphan quinidine 69 hyperplasia BPH 69 novel histone deacetylase 69 formerly LymphoStat B 69 SPRYCEL ® 69 Pivotal Phase 69 induce orthostatic hypotension 69 unresectable tumors 69 Panzem R NCD 69 AAG geldanamycin analog 69 DURECT proprietary 69 ALN PCS 69 Phase IIIb clinical 69 Central Retinal Vein 69 arthritis PsA 69 INTEGRILIN ® 69 treating abdominal aortic 69 thrombolytic agent 69 NeuroSTAT ® 69 BENLYSTA ® 69 molecular imaging radiopharmaceutical 69 Combination REOLYSIN R 69 Cypher Sirolimus 69 Generx TM 69 recurrent glioblastoma multiforme 69 Begins Dosing 69 headache nasopharyngitis 69 pseudobulbar affect PBA 69 MKC# 69 chronic thromboembolic pulmonary 69 Luveris R Ovidrel R 69 vidofludimus 69 lenalidomide Revlimid R 69 keloid scarring 69 hyaluronidase enzyme 69 tumor lysis syndrome 69 GAMMAGARD 69 Cleviprex TM clevidipine 69 ALN HPN 69 generation purine nucleoside 69 TRANSDUR ® 69 Solazed ™ 69 Endologix Powerlink System 69 Aflibercept 69 Neulasta R 69 pioglitazone HCl 69 TAXUS TM 69 Telik logo TELINTRA 69 FOLOTYN ® 69 Pegasys ® 69 cromolyn sodium 69 intravesical infusion therapy 69 ADP receptor antagonist 69 hoFH 69 evaluating picoplatin 69 By JENNIFER LEARN 69 oral beclomethasone dipropionate 69 oral picoplatin 69 severe hypersensitivity reactions 69 DDP# 69 GOUT 69 refractory gout 69 VELCADE melphalan 69 either acutely decompensated 69 Pegloticase 69 CRMD# 69 Xanafide 69 VP# [004] 69 Cardium Therapeutics TM 69 Phase #b/#a trial 69 metformin accumulation 69 investigational monoclonal antibody 69 Panzem R 69 candesartan cilexetil 69 Nebulized 69 candidate XP# 69 acyclovir Lauriad R 69 CIMZIA ™ 69 PRN FDA Approves 69 Demonstrates Positive 69 beta 1a 69 ELADUR TM 69 potent CYP#A# inhibitors 69 Ecallantide 69 monoclonal antibody conjugated 69 Initiate Clinical Trial 69 monoclonal antibody IgG1 Mab 69 Initiates Clinical Trial 69 dasatinib Sprycel 69 ATRA IV 69 serologically active systemic lupus 69 ZOLINZA 69 IMiDs ® 69 reslizumab 69 Phase III Pivotal 69 arsenic trioxide injection 69 fosbretabulin 69 aripiprazole Abilify 69 dependent kinase inhibitor 69 metaglidasen 69 bone marrow reticulin deposition 69 sorafenib tablets 69 peripheral arterial occlusive disease 69 Inhalation Solution 69 Evoltra ® 69 EnteroMedics proprietary neuroblocking technology 69 5 fluorouracil leucovorin 69 PLX STROKE targeting 69 LEUKINE 69 oral antidiabetic medication 69 Kuvan R 69 TLK# 69 PEGylated Fab fragment 69 LymphoStat B belimumab 69 intranasal formulation 69 sunitinib Sutent 69 vinorelbine tartrate 69 FOLFOX6 chemotherapy regimen 69 metastatic neuroendocrine tumors 69 VEGFR2 inhibitor 69 aldehyde dehydrogenase ALDH2 deficiency 68 Xcytrin R 68 coronary stent merged 68 overactive bladder syndrome 68 Granted Orphan Drug 68 orally inhaled migraine 68 nicardipine 68 interferon gamma 1b 68 thetreatment 68 Percutaneous Transluminal Coronary Angioplasty 68 PDX pralatrexate 68 Wafer polifeprosan 68 Zemiva TM 68 malignant ascites 68 Pemetrexed 68 trial evaluating PRX# 68 VALSTAR TM 68 bevacizumab Avastin ® 68 CINTREDEKIN BESUDOTOX 68 TAXUS Element Paclitaxel Eluting 68 cannabinor 68 Kit CD# positive 68 Hsp# Inhibitor 68 ergot derivatives 68 Mg Usa 68 J Am Coll 68 Resten NG 68 Complicated Skin 68 ABILIFY ® 68 HYVISC R 68 benzoic acid hyoscyamine sulfate 68 Orally administered 68 HCl PEPCID ® famotidine 68 PNP inhibitor 68 FOLFOX6 68 systemic immunosuppressive drugs 68 alpha interferons 68 trastuzumab Herceptin R 68 Inhalation Aerosol 68 TELINTRA 68 Ribavirin causes 68 albiglutide 68 mGluR5 negative 68 FASLODEX 68 GVAX ® 68 humanized interleukin 6 68 metastatic GIST 68 infusional 68 Oracea TM 68 pan histone deacetylase 68 Androxal TM 68 assessing T DM1 68 MYDICAR ® 68 Fludara ® 68 Erythropoietic therapies may 68 rALLy clinical trial 68 taxane resistant 68 endovascular stent graft 68 TKB# 68 Eluting Stent 68 R bisoprolol Euthyrox 68 PI3K/Akt pathway inhibitor 68 Chemophase 68 Diovan Exforge Tekturna Zelnorm 68 Diabetic Macular Edema DME 68 Dose Ranging Study 68 Phase 2a Clinical Trial 68 overactive bladder AA# 68 tiuxetan 68 Bepreve TM 68 de novo kidney transplant 68 TRANSDUR ™ 68 Biolimus A9 68 gastrointestinal disorders ATI 68 Opterone R 68 Methylnaltrexone 68 Bezielle 68 Kepivance 68 AzaSite Plus 68 oral ridaforolimus 68 hypereosinophilic syndrome 68 NASH Huntington 68 BrachySil TM 68 SPL# Gel vaginal microbicide 68 rheumatoid arthritis osteoarthritis ankylosing 68 R metformin Concor 68 Efficacy Trial 68 Phase III Clinical Trial 68 ribavirin RBV 68 samarium Sm 68 Adjunctive 68 Retisert ® 68 forodesine 68 Tezampanel 68 Fibrillex TM 68 Dacogen injection 68 YONDELIS 68 somatostatin analog 68 Copegus ® 68 receiving XGEVA 68 phase IIb study 68 Cytogen marketed 68 ribavirin Copegus ® 68 drug ISA# 68 Vascugel ® 68 Stedivaze 68 somatropin Kuvan R 68 Vitrasert R 68 recombinant tissue plasminogen 68 NDA Submission 68 sorafenib Nexavar 68 post herpetic neuralgia PHN 68 SomatoKine 68 prescribed proton pump 68 Kuvan TM sapropterin 68 urethral bulking agent 68 Initiated Phase 68 recurrent malignant glioma 68 CYP#A# CYP#D# 68 hormone LHRH antagonist 68 ALVESCO R 68 receiving chemoradiation therapy 68 IV Busulfex 68 occlusive disease 68 omega interferon 68 alfa 2a 68 Eluting Coronary Stent System 68 Albuferon TM 68 aflibercept VEGF Trap 68 inflammatory autoimmune diseases 68 liposomal formulation 68 squalamine 68 OAB overactive bladder 68 phase IIb clinical 68 ThermoDox R 68 NATRECOR ® 68 Renal Impairment 68 hypervascular tumors 68 DUROS 68 INSPIRE Trial Phase III 68 psoriasis rheumatoid arthritis 68 reduce serum phosphate 68 Eculizumab 68 Mg Uk 68 AVAPRO 68 #I TM# 68 Elagolix 68 Pafuramidine 68 Initiates Phase III 68 Syncria R 68 ORENCIA ® 67 oxaliplatin Eloxatin 67 riociguat 67 budesonide foam 67 Aztreonam lysine 67 Anturol TM 67 human C1 inhibitor 67 receiving VELCADE 67 Capesaris 67 severe hypercholesterolemia 67 ribavirin USP 67 cutaneous T 67 tartrate Inhalation Solution 67 antibody MAb 67 diarrhea fatigue asthenia 67 complement inhibitor eculizumab 67 Phase 2b Trial 67 anthracycline taxane 67 CINQUIL 67 COPEGUS R 67 CYPHER R Sirolimus Eluting 67 Amgen Neulasta R 67 CONTRAINDICATIONS 67 Testosterone MDTS R 67 xanthine oxidase inhibitor 67 interferon alpha IFN 67 morphometric vertebral fractures 67 Zenvia ™ 67 Pivotal Study 67 dual endothelin receptor antagonist 67 Fondaparinux 67 Soriatane 67 Kamada AAT 67 erythematosus SLE 67 failure ADHF 67 chronic eosinophilic leukemia 67 sodium benzoate prescription 67 Glypromate 67 r hGH 67 metastatic castration resistant 67 MGd 67 CIMZIA R 67 thalidomide Thalomid 67 inhibitor PPI 67 developing Bicifadine serotonin 67 markets HP Acthar 67 dihydrochloride 67 CD# CEA 67 Saizen ® 67 Gonal f R 67 signal detection CTSD 67 selective A2A adenosine receptor 67 topical gel formulation 67 cetuximab Erbitux ® 67 Xeloda ® 67 DG# compounds targeting 67 phenylketonuria PKU developed 67 Adjuvant Treatment 67 transthyretin TTR mediated amyloidosis 67 Novel Oral 67 5 HT3 antagonist 67 INS# [001] 67 treat benign prostatic 67 superficial femoral 67 virus HCV protease inhibitor 67 oral rivaroxaban 67 DELATESTRYL R 67 huC# DM4 67 liver resection surgeries 67 Prodarsan R 67 QuadraSphere 67 iobenguane 67 pan HDAC inhibitor 67 BRIM2 67 PROCTOCORT R 67 transthyretin mediated amyloidosis ATTR 67 Lactic acidosis 67 Immunotherapeutic 67 Tasigna prolongs 67 Xyfid TM 67 Study Evaluating 67 including acne photodamage 67 Dual Opioid 67 generation rotary VAD 67 macular edema secondary 67 urocortin 2 67 novel emulsion formulation 67 allogeneic HSCT 67 INTEGRILIN R 67 MKC# MKC# PP 67 Oral Fingolimod 67 Augment TM 67 LHRH receptor positive 67 Cimzia TM 67 mecarbil 67 occlusion CRVO 67 6R BH4 67 Eraxis 67 neutropenia dehydration dyspnea 67 NU# direct 67 Severe Sepsis 67 Pharmacokinetics PK 67 PrevOnco ™ 67 peripherally acting 67 relapsed multiple myeloma 67 ALN TTR# 67 relapsing remitting MS RRMS 67 Lixivaptan 67 uremic pruritus 67 Alfimeprase 67 relapsed refractory multiple myeloma 67 humanized therapeutic 67 phase III isavuconazole 67 PROVENGE ® 67 mertansine 67 AVASTIN 67 HGS ETR1 mapatumumab 67 Trofex 67 EVIZON ™ 67 Squalamine 67 hypertrichosis occurred 67 #mg BID [001] 67 GTC recombinant human 67 invasive candidiasis 67 Altera Nebulizer System 67 investigational pharmacologically unique 67 OZURDEX ® 67 selective modulator 67 Proquin XR 67 MEK Inhibitor 67 Interferon beta 1a 67 constipation OIC 67 lamotrigine Lamictal 67 LEP ETU 67 vaginal lidocaine product 67 Tarceva TM 67 calcineurin inhibitor 67 naïve HCV 67 FDA Approvals 67 Romiplostim 67 recurrent metastatic ovarian cancer 67 myelofibrosis polycythemia vera 67 BENLYSTA TM 67 volociximab 67 rosiglitazone maleate 67 Vidaza R 67 Patients Receiving 67 MGN# 67 nilotinib Tasigna ® 67 Testosterone MDTS ® 67 phenyl salicylate methylene blue 67 postoperative ileus POI 67 CCR9 antagonist 67 antiangiogenesis therapies 67 alfimeprase direct 67 OMNARIS Nasal Spray 67 ATACAND 67 Combo Stent 67 sitaxsentan 67 pediatric Crohn disease 67 Unigene nasal calcitonin 67 Initiate Phase 67 Investigational Oral 67 systemic hypotension 67 overactive bladder VANTAS R 67 Vicinium TM 67 polycythemia vera essential thrombocythemia 67 RhuDex ® 67 investigational antiplatelet agent 67 5 lipoxygenase inhibitor 67 QUADRAMET R 67 systemically administered 67 MYCAMINE 67 Zemiva ™ 67 BENICAR 67 non constipating irritable 67 Archexin 67 Proellex TM 67 Prochymal TM 67 cetuximab Erbitux R 67 HCD# [002] 67 ularitide 67 terlipressin 67 Vidaza azacitidine 67 telomerase therapeutic 67 Thiarabine 67 LHRH antagonists 67 highly purified pasteurized 67 Investigational Treatment 67 Cetrorelix 67 receiving INTRON 67 successfully commercialize Iluvien 67 Primary Hypercholesterolemia 67 IAP inhibitor 67 severe hepatomegaly 67 PresbyLens ® 67 Saizen R 67 Atypical Hemolytic Uremic Syndrome 67 SABER ™ 67 mechanical thrombectomy 67 tiapamil 67 Hormone Refractory Prostate Cancer 67 intravenous iv 67 disease GERD 67 opioid induced constipation OIC 67 TRIOLEX HE# APOPTONE HE# 67 INVANZ 67 evaluating T DM1 67 ELACYT 67 IRX 2 67 Xelox 67 EOquin TM 67 mitoxantrone plus 67 IIIa inhibitor 67 symptomatic hyponatremia 67 FS Antihemophilic Factor Recombinant 67 Sirolimus eluting Coronary Stent 67 included exfoliative dermatitis 67 RoACTEMRA 67 novel L DOS# 67 inhaled formulation 66 5 FU leucovorin 66 ASH Abstract # 66 UPLYSO 66 adjuvant GIST 66 rheumatoid arthritis RA psoriatic 66 Solulin 66 erythematosus 66 Shows Statistically Significant 66 Gemzar ® 66 dyskinesia PD LID 66 TELINTRA R 66 ZEVALIN ® 66 diabetic gastroparesis 66 alkylating agent 66 cardiometabolic diseases Glucophage 66 Serostim R 66 inhaled iloprost 66 sterile lidocaine patch 66 visilizumab 66 metabolic disorders Saizen R 66 vascular occlusive diseases 66 Tambocor 66 recurrent glioblastoma 66 oxypurinol 66 treat male hypogonadism 66 non topical formulations 66 severe gastroparesis 66 Infusion Reactions Severe 66 Auxilium anticipates 66 Pyridorin 66 Numoisyn Liquid 66 TM Aganocide 66 noninvasive outpatient 66 INCB# [003] 66 JAK2 Inhibitor 66 salmeterol fluticasone 66 Veronate R 66 sunitinib Sutent ® 66 Acute Attacks 66 Vascular Disrupting Agent 66 oral dual endothelin 66 registrational Phase 66 ® natalizumab 66 secondary hyperparathyroidism 66 esophagogastric 66 Phase IIa trials 66 orally inhaled 66 dyslipidemia hypertension diabetes 66 papillary renal cell carcinoma 66 Warfarin Coumadin 66 torsade de pointes 66 induced mucositis 66 Dupuytren Disease 66 Phase Ib IIa 66 Lymphoseek ® 66 MetroGel 66 individualized cellular immunotherapy 66 Azedra 66 markets COLAZAL 66 SNT MC# 66 SEPET TM 66 pentadentate logo R 66 gastrointestinal stromal tumors GIST 66 heparin induced thrombocytopenia 66 fondaparinux sodium 66 erlotinib Tarceva R 66 HuMax EGFr 66 dimebon latrepirdine 66 infectious diseases autoimmune diseases 66 Oral Calcitonin 66 Onalta ™ 66 EVIZON TM 66 clevidipine 66 torsemide ER 66 Phase 1b clinical trials 66 oral levofloxacin 66 DOR# 66 Microwave Ablation System 66 inhalation aerosol 66 sarcoma melanoma 66 recurrent genital herpes 66 ocular formulation 66 orally administered synthetic retinoid 66 Tasimelteon 66 Receives Orphan Drug Designation 66 Metastatic Melanoma 66 CIMZIA TM 66 GRNCM1 66 Traficet EN 66 PROTEGE 66 valve implantation 66 Liberte TM 66 liposomal amphotericin B 66 Long Term Efficacy 66 oral transdermal 66 atypical Hemolytic Uremic Syndrome 66 rALLy 66 IMPACT DCM 66 Diamondback #deg 66 Exelixis compounds 66 psoriatic arthritis PsA 66 rhITF 66 docetaxel Taxotere R 66 Severe VOD 66 nephropathic cystinosis cystinosis 66 Soliris TM eculizumab 66 includes Dideco CarboMedics 66 memantine HCl 66 exocrine pancreatic insufficiency EPI 66 Myelodysplastic Syndrome MDS 66 demonstrated antitumor activity 66 cytomegalovirus immune globulin 66 abobotulinumtoxinA 66 Demonstrates Significant 66 Simulect 66 PANVAC VF 66 receptor tyrosine kinase inhibitor 66 humanised monoclonal antibody 66 NMDA antagonist 66 diaper dermatitis complicated 66 IMiDs R 66 EDEMA3 trial 66 Aryplase 66 bleeding pallor 66 Phase Ib clinical trials 66 SYN# 66 metastatic CRC 66 post operative ileus 66 Xcellerated T Cells 66 benign prostatic hyperplasia enlarged 66 biliary tract cancer 66 idiopathic thrombocytopenic purpura ITP 66 Randomized Phase 66 Vascular Grafts 66 Parkinson disease levodopa induced 66 HDL Selective Delipidation 66 aspirin heparin 66 Daclizumab 66 biologic antibody 66 NSAID induced 66 opioid naive 66 Exherin TM 66 stent DES 66 transplantation HCT 66 Peginterferon alfa 2b 66 Golimumab 66 patients undergoing percutaneous 66 relapsed leukemia 66 COLAZAL R 66 pregabalin Lyrica 66 Plaque Psoriasis 66 Zoraxel 66 Ranolazine 66 adult chronic ITP 66 R abatacept 66 diabetic neuropathic pain 66 STELARA TM 66 PROMUS TM 66 induce remission 66 cryosurgical treatment 66 administered concomitantly 66 diuretics beta blockers 66 Navelbine ® 66 Aeolus Pharmaceuticals Announces 66 MCSP respectively 66 Hypotension 66 Abrupt discontinuation 66 Heterozygous Familial Hypercholesterolemia 66 diabetic peripheral neuropathic DPN 66 E2F Decoy 66 DEFLUX 66 chronic hemodialysis 66 recurrent NSCLC 66 Abbokinase 66 VISICOL R 66 IONSYS TM 66 Novartis Reclast 66 PRT# 66 steroid refractory GvHD 66 TYZEKA 66 endoluminal stent graft ELG 66 non metastatic osteosarcoma 66 POSIDUR TM 66 carcinoma mCRC 66 POSIDUR TM ELADUR TM 66 MOVIPREP R 66 familial amyloidotic polyneuropathy FAP 66 Adenoscan R 66 PMX # antibiotic 66 vesicoureteral reflux VUR malformation 66 Bucindolol 66 cancer neuroendocrine tumor 66 Tyrosine Kinase Inhibitor 66 PENTASA 66 tumors GIST 66 non resectable metastatic 66 BUPHENYL R sodium phenylbutyrate 66 briakinumab 66 Lupus Nephritis 66 resectable pancreatic cancer 66 unresectable malignant mesothelioma UMM 66 fluocinolone acetonide 66 Benign Prostatic Hyperplasia BPH 66 Injectable Bone Graft 66 Aerosurf 66 PROSTASCINT R 66 HeartMate ® 66 velafermin 66 EP #R 66 Soft Tissue Sarcoma 66 refractory metastatic colorectal cancer 66 GW# [003] 66 R rilonacept Injection 66 Shellgel TM injectable viscoelastic 66 evaluating mipomersen 66 SinuNase ™ 66 Cannabinor 66 BENICAR HCT 66 hemodynamically significant 66 metastatic pancreatic 66 Cetuximab Erbitux 66 recurrent glioma 66 Solesta TM 66 RhuDex TM 66 refractory recurrent 66 First Patient Enrolled 66 serum phosphorous 66 metastatic colorectal carcinoma 66 THR beta agonist 66 AERx R 66 abacavir lamivudine 66 subcutaneous formulation 66 REPRONEX R menotropins 66 distal embolization thrombus formation 66 R roscovitine CDK cyclin 66 Warner Chilcott Actonel 66 valsartan amlodipine 66 rasagiline tablets 66 aplastic anemia AA 66 gefitinib Iressa 66 Acute Decompensated Heart Failure 66 DU #b 66 vaginally administered lidocaine 66 Drug Eluting Stent System 66 Rhucin ® recombinant 66 thoracoscopic lobectomy 66 Factor VIIa 66 Gliadel Wafer 66 EDARBI 66 phase IIb trial 66 Soliris eculizumab 66 lupus renal disease 66 venous stasis ulcers 66 MEND CABG 66 lymphoid malignancies 66 Sudhir Agrawal D.Phil 66 paroxysmal supraventricular tachycardia 66 vaccines oncolytic virus 66 IMiDs 66 IMiDs ® compound 66 PGL# 66 itraconazole Sporanox 66 adenosine injection 66 Accelerated Partial Breast Irradiation 66 PERLANE 66 Trial Evaluating 66 Budesonide foam crofelemer 66 Locteron ® 66 hormone refractory metastatic prostate 66 fully bioabsorbable 66 chronic myocardial ischemia 66 Degarelix 66 Hylan GF 66 acute PAO 66 evaluating Actimmune 66 trastuzumab Herceptin ® 66 REPRONEX ® menotropins 66 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 66 superficial basal cell carcinoma 66 Regenerative Cells 66 cMET 66 AMMONUL R 66 Intra arterial 66 chemosensitizer 65 valtorcitabine 65 Aurexis R 65 Solzira TM 65 octreotide acetate 65 mGluR2 positive 65 bevacizumab Avastin R 65 non valvular atrial 65 P#X# antagonist 65 Interferon beta 65 events thrombocytopenia neutropenia 65 Genasense R oblimersen 65 Quinamed 65 R famotidine 65 aerosolized AAT 65 headache abdominal pain 65 R#/MEM 65 novel synthetic PEGylated 65 certolizumab 65 familial hypercholesterolemia FH 65 ALN VSP Phase 65 Monopril 65 descending thoracic 65 ® bortezomib 65 oral proteasome inhibitor 65 iloprost synthetic compound 65 multicenter Phase III 65 Durezol TM 65 CHEAP ONLINE PHARMACY LOW 65 verteporfin 65 containing granisetron 65 cardiac myosin activator omecamtiv 65 omecamtiv mecarbil 65 plus prednisone prednisolone 65 cilengitide 65 Bone Graft 65 relapsing multiple sclerosis 65 EmbraceAC 65 implantable centrifugal rotary 65 Vicriviroc 65 arterial thrombosis 65 adalimumab Humira 65 G CSFs 65 Diabetic Macular Edema 65 Lisofylline 65 mycophenolic acid 65 Pimavanserin 65 LEVAQUIN ® 65 candidate AQ4N 65 MTP inhibitor 65 Phase IIb Clinical Trial 65 IOP lowering 65 phase IIa clinical 65 ™ pralatrexate injection 65 stable angina pectoris 65 ankylosing spondylitis psoriatic arthritis 65 abdominal aortic aneurysms AAA 65 Urocortin 2 65 neovascular diseases 65 painful diabetic neuropathy 65 prostate cancer HRPC 65 TAXUS Liberté stent 65 TBC# 65 IMA# 65 p# inhibitor 65 Liprotamase 65 glycoprotein IIb IIIa inhibitor 65 PEGylated interferon beta 1a 65 unfractionated heparin UFH 65 R brand arformoterol 65 5 Fluorouracil 65 mu opioid receptor antagonist 65 TRO# 65 HuCAL PLATINUM ® CysDisplay 65 pancreatic insufficiency 65 Sanvar R 65 TAXUS Express Stent 65 Hedgehog Pathway Inhibitor 65 ENL recurrence 65 IIb clinical trial 65 Acute Ischemic Stroke 65 unstable angina UA 65 nasal calcitonin product 65 carcinoma HCC